SOSV

SOSV is a global venture capital firm founded in 1995 and headquartered in Princeton, New Jersey. Specializing in seed-to-growth stage investments, SOSV operates multiple accelerator programs worldwide, including HAX for hardware, IndieBio and RebelBio for life sciences, Chinaccelerator and MOX for cross-border internet ventures, Food-X for innovative food solutions, and dlab for blockchain technology. The firm focuses on investments in revolutionary deep technologies aimed at improving human and planetary health, as well as cross-border markets, particularly in Asia. SOSV invests in approximately 150 startups annually, providing support through its resources to accelerate product development and scaling. Over its two-decade history, SOSV has established a strong reputation, consistently ranking among the top venture capital firms globally.

Michael Aberman

Partner

Lindsay Atkenson

Analyst

Hugh Bowen

Associate

Po Bronson

General Partner

Stephen Chambers

Partner

Navin Danapal

SEA Director

Hiruy Ephrem

Analyst

Sheng Ge

Partner, Investments Operations

Weichang Ge

Analyst

TR Harrington

Partner

Bill Liao

General Partner

Ching-Ping Lin

Partner

Stephen McCann

CFO and General Partner

Carthach McCarthy

CFO

Yuan-Ting Meng

Analyst

Paul Monaghan

Principal

Eric Ramsay

Analyst

Pae Wu

General Partner

Sabriya Stukes Ph.D

Partner

Past deals in Portugal

Criam

Seed Round in 2021
Criam is a biotechnology company based in Braga, Portugal, founded in 2015, that focuses on developing medical devices for blood type analysis and disease detection. The company's flagship product, also named Criam, enables rapid and affordable blood test analysis, allowing users to receive immediate information about their health. This medical device can detect various diseases, including HIV, Brucella, tick fever, syphilis, mononucleosis, and meningitis. By positioning itself in the Point-of-Care diagnostic segment, Criam aims to empower individuals with timely health information and contribute to the global monitoring and control of diseases.

Criam

Seed Round in 2021
Criam is a biotechnology company based in Braga, Portugal, founded in 2015, that focuses on developing medical devices for blood type analysis and disease detection. The company's flagship product, also named Criam, enables rapid and affordable blood test analysis, allowing users to receive immediate information about their health. This medical device can detect various diseases, including HIV, Brucella, tick fever, syphilis, mononucleosis, and meningitis. By positioning itself in the Point-of-Care diagnostic segment, Criam aims to empower individuals with timely health information and contribute to the global monitoring and control of diseases.

Maven Pet

Pre Seed Round in 2021
Maven is a SaaS pet tech startup that provides a personal vet to track the pet’s safety and health 24/7. It focuses on using technology to improve the quality of life for pets, as well as offering pet owners peace of mind and a way to keep track of their pet's safety, health, and well-being on a continual basis through their own personal veterinarian. It was started by the founders of Findster Technologies in 2021 and is based in Porto, Portugal.

Misk

Seed Round in 2018
Misk is a mobile platform that enhances the dining experience by connecting individuals through social networks to share restaurant recommendations. It aims to transform word-of-mouth dining suggestions into an online community, allowing users to make informed decisions about where to eat or drink based on their friends' insights. The platform also provides tools for brands to engage with a targeted audience, helping to boost brand awareness and increase revenue. By facilitating these connections, Misk enables food enthusiasts to discover new dining options while assisting businesses in attracting customers.

Nuada

Convertible Note in 2018
Nuada is a company based in Braga, Portugal, focused on developing innovative systems that enhance hand function. Its products are designed for use in healthcare, sports, and professional activities, offering a safe, lightweight, and compact solution. Nuada's technology incorporates thin, breathable, and flexible smart textiles that can be customized by users. This unique enhancement aims to be a non-intrusive and affordable everyday wearable, allowing individuals to improve their hand function without being aware of the device.

Vetherapy

Seed Round in 2018
Vetherapy is a biotechnology company based in San Francisco, California, specializing in veterinary regenerative medicine and tissue engineering. Founded in 2015, the company develops stem cell therapy products for cats, dogs, and horses, aimed at accelerating wound healing and treating autoimmune and inflammatory diseases. Vetherapy emphasizes quality and safety in its processes, which include the isolation, expansion, and cryopreservation of stem cells, as well as the preparation of platelet-rich plasma. By providing veterinarians with access to a stem cell and PRP bank through their cryopreservation services, Vetherapy ensures that these therapeutic products are readily available for immediate use, addressing various clinical needs for animal patients.

Criam

Convertible Note in 2018
Criam is a biotechnology company based in Braga, Portugal, founded in 2015, that focuses on developing medical devices for blood type analysis and disease detection. The company's flagship product, also named Criam, enables rapid and affordable blood test analysis, allowing users to receive immediate information about their health. This medical device can detect various diseases, including HIV, Brucella, tick fever, syphilis, mononucleosis, and meningitis. By positioning itself in the Point-of-Care diagnostic segment, Criam aims to empower individuals with timely health information and contribute to the global monitoring and control of diseases.

Nuada

Convertible Note in 2017
Nuada is a company based in Braga, Portugal, focused on developing innovative systems that enhance hand function. Its products are designed for use in healthcare, sports, and professional activities, offering a safe, lightweight, and compact solution. Nuada's technology incorporates thin, breathable, and flexible smart textiles that can be customized by users. This unique enhancement aims to be a non-intrusive and affordable everyday wearable, allowing individuals to improve their hand function without being aware of the device.

B2 Impact

Seed Round in 2017
B2Holding ASA provides debt solutions for banks and institutional vendors. The company’s portfolio of business consists of purchase, management, and collection of unsecured and secured non-performing loans. It services include debt purchase and collection, credit information third party debt collection, and consumer lending, as well as telemarketing and fraud prevention services. It principally operates in Norway, Sweden, Denmark, Finland, Estonia, Latvia, Lithuania, Poland, Croatia, Slovenia, Serbia, Montenegro, Bosnia-Herzegovina, Austria, the Czech Republic, Hungary, Spain, Portugal, Italy, France, Bulgaria, Romania, Greece, and Cyprus. B2Holding SAS was founded in 2011 and is headquartered in Oslo, Norway.

Nuada

Seed Round in 2017
Nuada is a company based in Braga, Portugal, focused on developing innovative systems that enhance hand function. Its products are designed for use in healthcare, sports, and professional activities, offering a safe, lightweight, and compact solution. Nuada's technology incorporates thin, breathable, and flexible smart textiles that can be customized by users. This unique enhancement aims to be a non-intrusive and affordable everyday wearable, allowing individuals to improve their hand function without being aware of the device.

Criam

Convertible Note in 2016
Criam is a biotechnology company based in Braga, Portugal, founded in 2015, that focuses on developing medical devices for blood type analysis and disease detection. The company's flagship product, also named Criam, enables rapid and affordable blood test analysis, allowing users to receive immediate information about their health. This medical device can detect various diseases, including HIV, Brucella, tick fever, syphilis, mononucleosis, and meningitis. By positioning itself in the Point-of-Care diagnostic segment, Criam aims to empower individuals with timely health information and contribute to the global monitoring and control of diseases.

Criam

Seed Round in 2016
Criam is a biotechnology company based in Braga, Portugal, founded in 2015, that focuses on developing medical devices for blood type analysis and disease detection. The company's flagship product, also named Criam, enables rapid and affordable blood test analysis, allowing users to receive immediate information about their health. This medical device can detect various diseases, including HIV, Brucella, tick fever, syphilis, mononucleosis, and meningitis. By positioning itself in the Point-of-Care diagnostic segment, Criam aims to empower individuals with timely health information and contribute to the global monitoring and control of diseases.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.